Robert Kirkman
2012 - Oncothyreon
In 2012, Robert Kirkman earned a total compensation of $918.7K as President, Chief Executive Officer and Director at Oncothyreon, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,900 |
|---|---|
| Option Awards | $336,000 |
| Salary | $410,000 |
| Other | $12,792 |
| Total | $918,692 |
Kirkman received $410K in salary, accounting for 45% of the total pay in 2012.
Kirkman also received $159.9K in non-equity incentive plan, $336K in option awards and $12.8K in other compensation.
Rankings
In 2012, Robert Kirkman's compensation ranked 6,464th out of 11,487 executives tracked by ExecPay. In other words, Kirkman earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,464 out of 11,487 | 44th |
Division Services | 970 out of 1,721 | 44th |
Major group Engineering, Accounting, Research, Management, And Related Services | 82 out of 165 | 50th |
Industry group Research, Development, And Testing Services | 32 out of 56 | 43rd |
Industry Commercial Physical and Biological Research | 32 out of 51 | 37th |
Source: SEC filing on April 23, 2015.
Kirkman's colleagues
We found four more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2012.